Suppr超能文献

瑞典辅助生殖技术受孕儿童的印迹障碍。

Imprinting disorders in children conceived with assisted reproductive technology in Sweden.

机构信息

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Fertil Steril. 2024 Oct;122(4):706-714. doi: 10.1016/j.fertnstert.2024.05.168. Epub 2024 Jun 1.

Abstract

OBJECTIVE

To assess whether the use of assisted reproductive technology (ART) therapy for conception is associated with imprinting disorders in children and the impact of parental factors related to infertility.

DESIGN

A nationwide register-based cohort study.

SETTING

Swedish national registers and nationwide quality IVF register.

PATIENT(S): All liveborn singletons in Sweden (N = 2,084,127) between 1997 and 2017 with follow-up to December 31, 2018.

INTERVENTION(S): The use of specific methods implemented in ART.

MAIN OUTCOME MEASURE(S): The International Classification of Diseases version 10 was used to identify three distinct imprinting disorder groups: Beckwith-Wiedemann syndrome (BWS), Prader-Willi syndrome (PWS), and Silver-Russell syndrome (SRS), as well as central precocious puberty. The Cox model combined with inverse probability treatment weights was used to estimate the weighted hazard ratio (wHR) with a 95% confidence interval (CI), accounting for multiple confounders.

RESULT(S): A total of 1,044 children were diagnosed with the disorders of interest, and 52 of them were conceived using ART therapy. The overall risk of being diagnosed with any of the studied imprinting disorders was elevated in children conceived using ART therapy compared with all other children (HR, 1.84; 95% CI, 1.38-2.45). After adjusting for parental background factors, the association was partially attenuated (wHR, 1.50; 95% CI, 0.97-2.32), but remained in the weighted comparison restricted to children of couples with known infertility (wHR, 1.52; 95% CI, 1.05-2.21). For the specific diagnoses of PWS/SRS, and BWS compared with children of couples with known infertility, children conceived with ART therapy showed a small excess risk, which could not be distinguished from the null (wHR, 1.56; 95% CI, 0.93-2.62 and 1.80; 95% CI, 0.99-3.28, respectively). Further subgroup analysis showed that the combined use of intracytoplasmic sperm injection and cryopreserved embryos was associated with a higher risk of both PWS/SRS (wHR, 4.60; 95% CI, 1.72-12.28) and BWS (wHR, 6.69; 95% CI, 2.09-21.45). The number of central precocious puberty cases in children conceived using ART therapy was too small (N = 3) to make any meaningful inference.

CONCLUSION(S): The combined use of intracytoplasmic sperm injection and cryopreserved embryos was associated with small elevated risks of PWS/SRS, and BWS in children, independent of parental factors related to infertility.

摘要

目的

评估使用辅助生殖技术(ART)治疗受孕是否与儿童印迹障碍有关,以及与不孕相关的父母因素的影响。

设计

全国注册队列研究。

地点

瑞典全国登记处和全国优质体外受精登记处。

患者

1997 年至 2017 年间瑞典所有活产单胎(N=2084127),随访至 2018 年 12 月 31 日。

干预措施

使用特定的 ART 方法。

主要观察指标

采用国际疾病分类第 10 版(ICD-10)对 3 种不同的印迹障碍组进行识别:贝克威思-威德曼综合征(BWS)、普瑞德威利综合征(PWS)和西尔弗-拉塞尔综合征(SRS),以及中枢性性早熟。采用 Cox 模型结合逆概率治疗权重来估计加权风险比(wHR)及其 95%置信区间(CI),同时考虑多种混杂因素。

结果

共诊断出 1044 名符合条件的患儿,其中 52 名患儿通过 ART 治疗受孕。与所有其他儿童相比,使用 ART 治疗受孕的儿童被诊断为任何研究印迹障碍的风险总体升高(HR,1.84;95%CI,1.38-2.45)。调整父母背景因素后,该关联部分减弱(wHR,1.50;95%CI,0.97-2.32),但在仅针对已知不孕夫妇所生子女的加权比较中仍存在(wHR,1.52;95%CI,1.05-2.21)。对于 PWS/SRS 和 BWS 的具体诊断,与已知不孕夫妇所生子女相比,通过 ART 治疗受孕的儿童表现出略高的风险,但与零风险无法区分(wHR,1.56;95%CI,0.93-2.62 和 1.80;95%CI,0.99-3.28)。进一步的亚组分析显示,胞浆内精子注射和冷冻胚胎的联合使用与 PWS/SRS(wHR,4.60;95%CI,1.72-12.28)和 BWS(wHR,6.69;95%CI,2.09-21.45)的风险升高有关。通过 ART 治疗受孕的儿童的中枢性性早熟病例数量太少(N=3),无法得出任何有意义的结论。

结论

胞浆内精子注射和冷冻胚胎的联合使用与儿童 PWS/SRS 和 BWS 的小风险升高有关,这与不孕相关的父母因素无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验